Danilov AV, Li H, Shadman M, Rimsza L, Zebari A, Smith SM, LeBlanc M, Friedberg JW, Carlson C, Song JY. Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial. haematol [Internet]. 2025Dec.1 [cited 2025Dec.5];110(12):3145-9. Available from: https://haematologica.org/article/view/12159